CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene...

Area of Science:

• Molecular Biology
• Oncology
• Gene Therapy

Background:

• Gene therapy for cancer utilizes specific promoters overexpressed in tumor cells.
• Current tumor-specific promoters often exhibit low activity, limiting therapeutic gene expression.
• Enhancing promoter activity while maintaining tumor specificity is crucial for effective cancer gene therapy.

Purpose of the Study:

• To evaluate the enhancer potential of the MSLN gene-derived CanScript sequence.
• To determine if CanScript can increase the activity of tumor-specific promoters.
• To assess the application of CanScript in cancer-targeting gene therapy.

Main Methods:

• Utilized a luciferase reporter DNA construct for gene expression analysis.
• Performed in vitro cell transfection assays.
• Employed in vivo mouse tumor models to assess promoter activity.

Main Results:

• CanScript demonstrated approximately 25% of CAG promoter activity in MSLN-expressing tumor cells.
• Tandem repeat copies of CanScript enhanced transcription in a dose-dependent manner.
• Coupling CanScript with tumor-active promoters increased overall promoter activity.

Conclusions:

• CanScript functions as a potent enhancer sequence for MSLN-expressing tumor cells.
• Incorporating CanScript into gene constructs can significantly boost promoter activity.
• CanScript holds promise for enhancing the efficacy of cancer gene therapy strategies.